drugset / Trial / NCT00717197
Study of Capecitabine to Treat Recurrent High Grade Gliomas
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if capecitabine is effective in the treatment of high grade gliomas that have returned after completing treatment.
Timeline
- Start
- 2008-07
- Primary completion
- 2012-03
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |